Artificial Intelligence | Machine Learning | Machine Perception Owkin | AI for Medical Research


Enterprise, Machine Learning, Drug Development, Clinical Trials, Healthcare New York , United States

Owkin

Artificial Intelligence | Machine Learning | Machine Perception


Owkin | AI for Medical Research

Owkin

Machine Learning, Drug Development, Clinical Trials, Healthcare


New York , United States

Owkin is a French-American startup that deploys AI and Federated Learning for medical research. The company deploys AI and federated learning for medical research and aims to empower researchers in hospitals, universities, and pharmaceutical companies to understand why drug efficacy varies from patient to patient, enhance the drug development process, and identify the best drug for the right patient to improve treatment outcomes. It is backed by investors such as F-Prime Capital & Eight Roads Ventures, GV, Otium Ventures, Cathay Innovation, and NJF Capital as well as a scientific board.

It was co-founded in 2016 by Thomas Clozel, a hematologist oncologist and researcher, and Gilles Wainrib, a computer science teacher-researcher in New York, New York. We combine cutting-edge machine learning and biology to advance drug discovery. We blend human insight with safe and fast data access to train high-performance models. Our cutting-edge machine learning methodologies de-risk and accelerate clinical trials. Building useful clinical tools to identify patients and boost their access to better treatment options.

 
 

   Total Funding: US $74.1M

   Funding Stage: N/A

   Business Stage: Scaling Up

   Market: B2B

   Company Size: 51 to 100

   Founded: 2016

Jun 2022

  • Owkin Announced Strategic Collaboration with Bristol Myers Squibb

Nov 2020

  • Owkin Announces a New Collaboration to Identify High Immunogenic Epitopes and Candidates for COVID-19 and Coronaviruses Future Vaccines

Oct 2020

  • Owkin Wins 2020 MICCAI Distributive and Federated Learning Workshop?s Best Paper Award for its Siloed Federated Learning for Multi-Centric Histopathology Datasets Paper

May 2020

  • Owkin Launches the Collaborative COVID-19 Open AI Consortium (COAI)
 
 

AI/ML Startup DealsGet Free Access

Date

Round

$ Raised

Investors

06/08/2022

Funded

$50M

Bristol Myers Squibb

Date : 06/08/2022

Round: Funded

$ Raised: $50M

Investors: Bristol Myers Squibb

11/18/2021

Funded

$180M

Sanofi

Date : 11/18/2021

Round: Funded

$ Raised: $180M

Investors: Sanofi

 

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Owkin

 
 
 
Thomas Clozel


Thomas Clozel
Co-Founder & CEO

Adrian Gonzalez Lopez

Adrian Gonzalez Lopez
CTO

Anna Bondarenko


Anna Bondarenko
COO

Hubert Chaperon


Hubert Chaperon
Chief Operating Officer

Mathieu Galtier

Mathieu Galtier
Chief Product Officer

Sonia Grouchko

Sonia Grouchko
Chief of Staff

Gilles Wainrib

Gilles Wainrib
Co-founder and CSO

 
 

Owkin is growing. Want to work at Owkin? Owkin is hiring. Join team at Owkin

 

View All

View All AI/ML Jobs

Biostatistician/Clinical Data Scientist

Paris, Paris

Machine Learning Scientist - Medical Imaging - Intern

Paris, Paris

Machine Learning Engineer

Paris, Paris

Quality Assurance Intern

Paris, Paris

Stage/Alternance Achats

Paris, Paris

 
 
appengine.ai

World's Most Promising AI/ML Startups